-
Ruxolitinib
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Ruxolitinib Myelofibrosis Novartis Jul. 6, 2024 -
Crisaborole
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Crisaborole Dermatitis ya Atopic ndi Eczema Pfizer Jun. 11, 2026 -
Vericiguat
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Vericiguat Kulephera kwa mtima Bayer ndi MSD Mayi.24, 2031 -
Abrocitinib
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Abrocitinib Dermatitis ya Atopic Pfizer Feb. 11, 2034 -
Rimegepant
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Rimegepant Mutu wa Migraine Biohaven Feb. 22, 2031 -
Elagolix 834153-87-6
Dzina la API Chizindikiro Kufotokozera US DMF EU DMF CEP ElagolixCAS:834153-87-6 Endometriosis M'nyumba -
Relugolix 737789-87-6
Dzina la API Chizindikiro Kufotokozera US DMF EU DMF CEP Ribociclib CAS: 737789-87-6 Antineoplastic M'nyumba -
Venetoclax 1257044-40-8
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Venetoclax 1257044-40-8 Mtengo CLL Abbvie Jun.27,2031 -
Velpatasvir (PVP)
Dzina la API Chizindikiro Kufotokozera US DMF EU DMF CEP Velpatasvir (PVP) HCV M'nyumba √ -
Thalidomide
Dzina la API Chizindikiro Kufotokozera US DMF EU DMF CEP Thalidomide Oncology mankhwala USP/EP -
Ticagrelor
Dzina la API Chizindikiro Kufotokozera US DMF EU DMF CEP Ticagrelor Anticoagulant M'nyumba 28984 √
